M1 KLINIKEN AG (M12.DE) Stock Fundamental Analysis
Europe - FRA:M12 - DE000A0STSQ8 - Common Stock
13.64 EUR
-0.42 (-2.99%)
M12 gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 28 industry peers in the Health Care Providers & Services industry. M12 gets an excellent profitability rating and is at the same time showing great financial health properties. M12 is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings could make M12 a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
M12 had positive earnings in the past year.
In the past year M12 had a positive cash flow from operations.
Each year in the past 5 years M12 has been profitable.
In the past 5 years M12 always reported a positive cash flow from operatings.
1.2 Ratios
M12's Return On Assets of 8.53% is amongst the best of the industry. M12 outperforms 96.43% of its industry peers.
With an excellent Return On Equity value of 15.10%, M12 belongs to the best of the industry, outperforming 82.14% of the companies in the same industry.
M12 has a better Return On Invested Capital (12.86%) than 96.43% of its industry peers.
The Average Return On Invested Capital over the past 3 years for M12 is above the industry average of 5.66%.
The last Return On Invested Capital (12.86%) for M12 is above the 3 year average (7.72%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.53% | ||
| ROE | 15.1% | ||
| ROIC | 12.86% |
ROA(3y)5.18%
ROA(5y)4.73%
ROE(3y)9.59%
ROE(5y)9.22%
ROIC(3y)7.72%
ROIC(5y)6.16%
1.3 Margins
With a decent Profit Margin value of 4.72%, M12 is doing good in the industry, outperforming 75.00% of the companies in the same industry.
In the last couple of years the Profit Margin of M12 has declined.
Looking at the Operating Margin, with a value of 7.89%, M12 is in the better half of the industry, outperforming 67.86% of the companies in the same industry.
M12's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 18.75%, M12 is doing worse than 60.71% of the companies in the same industry.
M12's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.89% | ||
| PM (TTM) | 4.72% | ||
| GM | 18.75% |
OM growth 3Y27.08%
OM growth 5Y-5.31%
PM growth 3Y18.61%
PM growth 5Y-17.82%
GM growth 3Y2.18%
GM growth 5Y-14.45%
2. Health
2.1 Basic Checks
M12 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, M12 has less shares outstanding
The number of shares outstanding for M12 has been increased compared to 5 years ago.
M12 has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 5.15 indicates that M12 is not in any danger for bankruptcy at the moment.
M12 has a Altman-Z score of 5.15. This is amongst the best in the industry. M12 outperforms 96.43% of its industry peers.
The Debt to FCF ratio of M12 is 0.71, which is an excellent value as it means it would take M12, only 0.71 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of M12 (0.71) is better than 100.00% of its industry peers.
M12 has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
M12 has a better Debt to Equity ratio (0.07) than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 0.71 | ||
| Altman-Z | 5.15 |
ROIC/WACC1.8
WACC7.16%
2.3 Liquidity
A Current Ratio of 1.91 indicates that M12 should not have too much problems paying its short term obligations.
M12 has a Current ratio of 1.91. This is amongst the best in the industry. M12 outperforms 85.71% of its industry peers.
M12 has a Quick Ratio of 1.07. This is a normal value and indicates that M12 is financially healthy and should not expect problems in meeting its short term obligations.
M12's Quick ratio of 1.07 is fine compared to the rest of the industry. M12 outperforms 67.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.91 | ||
| Quick Ratio | 1.07 |
3. Growth
3.1 Past
M12 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 55.90%, which is quite impressive.
Measured over the past 5 years, M12 shows a small growth in Earnings Per Share. The EPS has been growing by 7.97% on average per year.
M12 shows a small growth in Revenue. In the last year, the Revenue has grown by 7.23%.
The Revenue has been growing by 34.44% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)55.9%
EPS 3Y21.62%
EPS 5Y7.97%
EPS Q2Q%-10.77%
Revenue 1Y (TTM)7.23%
Revenue growth 3Y2.54%
Revenue growth 5Y34.44%
Sales Q2Q%3.58%
3.2 Future
M12 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.44% yearly.
The Revenue is expected to grow by 8.24% on average over the next years. This is quite good.
EPS Next Y4.33%
EPS Next 2Y14.78%
EPS Next 3Y19.44%
EPS Next 5YN/A
Revenue Next Year5.72%
Revenue Next 2Y6.69%
Revenue Next 3Y6.7%
Revenue Next 5Y8.24%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 16.63, M12 is valued correctly.
Based on the Price/Earnings ratio, M12 is valued a bit cheaper than the industry average as 67.86% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.27. M12 is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 14.84 indicates a correct valuation of M12.
60.71% of the companies in the same industry are more expensive than M12, based on the Price/Forward Earnings ratio.
M12's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.77.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.63 | ||
| Fwd PE | 14.84 |
4.2 Price Multiples
67.86% of the companies in the same industry are more expensive than M12, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of M12 indicates a somewhat cheap valuation: M12 is cheaper than 75.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.07 | ||
| EV/EBITDA | 8.19 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
M12 has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as M12's earnings are expected to grow with 19.44% in the coming years.
PEG (NY)3.84
PEG (5Y)2.09
EPS Next 2Y14.78%
EPS Next 3Y19.44%
5. Dividend
5.1 Amount
M12 has a Yearly Dividend Yield of 3.70%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.57, M12 pays a better dividend. On top of this M12 pays more dividend than 96.43% of the companies listed in the same industry.
M12's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.7% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
DPN/A
EPS Next 2Y14.78%
EPS Next 3Y19.44%
FRA:M12 (9/15/2025, 7:00:00 PM)
13.64
-0.42 (-2.99%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners0.96%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap267.89M
Analysts85
Price Target27.03 (98.17%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.7% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-5.33%
EPS NY rev (3m)-5.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.61%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.63 | ||
| Fwd PE | 14.84 | ||
| P/S | 0.79 | ||
| P/FCF | 9.07 | ||
| P/OCF | 8.77 | ||
| P/B | 2.52 | ||
| P/tB | 14.38 | ||
| EV/EBITDA | 8.19 |
EPS(TTM)0.82
EY6.01%
EPS(NY)0.92
Fwd EY6.74%
FCF(TTM)1.5
FCFY11.03%
OCF(TTM)1.56
OCFY11.4%
SpS17.27
BVpS5.4
TBVpS0.95
PEG (NY)3.84
PEG (5Y)2.09
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.53% | ||
| ROE | 15.1% | ||
| ROCE | 18.56% | ||
| ROIC | 12.86% | ||
| ROICexc | 15.5% | ||
| ROICexgc | 57.73% | ||
| OM | 7.89% | ||
| PM (TTM) | 4.72% | ||
| GM | 18.75% | ||
| FCFM | 8.71% |
ROA(3y)5.18%
ROA(5y)4.73%
ROE(3y)9.59%
ROE(5y)9.22%
ROIC(3y)7.72%
ROIC(5y)6.16%
ROICexc(3y)9.69%
ROICexc(5y)8.26%
ROICexgc(3y)31.7%
ROICexgc(5y)24.88%
ROCE(3y)11.15%
ROCE(5y)8.88%
ROICexcg growth 3Y38.16%
ROICexcg growth 5Y31.27%
ROICexc growth 3Y22.22%
ROICexc growth 5Y5.12%
OM growth 3Y27.08%
OM growth 5Y-5.31%
PM growth 3Y18.61%
PM growth 5Y-17.82%
GM growth 3Y2.18%
GM growth 5Y-14.45%
F-Score9
Asset Turnover1.81
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 0.71 | ||
| Debt/EBITDA | 0.23 | ||
| Cap/Depr | 19.3% | ||
| Cap/Sales | 0.29% | ||
| Interest Coverage | 17.5 | ||
| Cash Conversion | 95.72% | ||
| Profit Quality | 184.48% | ||
| Current Ratio | 1.91 | ||
| Quick Ratio | 1.07 | ||
| Altman-Z | 5.15 |
F-Score9
WACC7.16%
ROIC/WACC1.8
Cap/Depr(3y)22.84%
Cap/Depr(5y)24.89%
Cap/Sales(3y)0.41%
Cap/Sales(5y)0.51%
Profit Quality(3y)272.44%
Profit Quality(5y)207.18%
High Growth Momentum
Growth
EPS 1Y (TTM)55.9%
EPS 3Y21.62%
EPS 5Y7.97%
EPS Q2Q%-10.77%
EPS Next Y4.33%
EPS Next 2Y14.78%
EPS Next 3Y19.44%
EPS Next 5YN/A
Revenue 1Y (TTM)7.23%
Revenue growth 3Y2.54%
Revenue growth 5Y34.44%
Sales Q2Q%3.58%
Revenue Next Year5.72%
Revenue Next 2Y6.69%
Revenue Next 3Y6.7%
Revenue Next 5Y8.24%
EBIT growth 1Y69.16%
EBIT growth 3Y30.31%
EBIT growth 5Y27.31%
EBIT Next Year28.34%
EBIT Next 3Y33.77%
EBIT Next 5YN/A
FCF growth 1Y49.16%
FCF growth 3Y27.23%
FCF growth 5YN/A
OCF growth 1Y46.7%
OCF growth 3Y24.88%
OCF growth 5YN/A